CRISP3 expression drives prostate cancer invasion and progression.

Identifying the factors stimulating prostate cancer cells migration and invasion has the potential to bring new therapeutic targets to the clinic. Cysteine-rich secretory protein 3 (CRISP3) is one of the most highly up-regulated proteins during the transition of a healthy human prostatic epithelium to prostate cancer. Here we show using a genetically engineered mouse model of prostate cancer, that CRISP3 production greatly facilitates disease progression from carcinoma in situ to invasive prostate cancer in vivo. This interpretation was confirmed using both human and mouse prostate cancer cell lines, which showed that exposure to CRISP3 enhanced cell motility and invasion. Further, using mass spectrometry, we show that CRISP3 induces changes in abundance of a subset of cell-cell adhesion proteins, including LASP1 and TJP1 both in vivo and in vitro. Collectively, these data identify CRISP3 as being pro-tumorigenic in the prostate and validate it as a potential target for therapeutic intervention.

[1]  K. Tsai,et al.  Tight Junction Protein 1 Dysfunction Contributes to Cell Motility in Bladder Cancer , 2018, AntiCancer Research.

[2]  S. Mahale,et al.  Androgen receptor mediated epigenetic regulation of CRISP3 promoter in prostate cancer cells , 2018, The Journal of Steroid Biochemistry and Molecular Biology.

[3]  T. H. van der Kwast,et al.  A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies. , 2017, European urology.

[4]  R. Weinberg,et al.  EMT, cell plasticity and metastasis , 2016, Cancer and Metastasis Reviews.

[5]  T. Saku,et al.  Aberrant expression of the tight junction molecules claudin-1 and zonula occludens-1 mediates cell growth and invasion in oral squamous cell carcinoma. , 2016, Human pathology.

[6]  R. Pearson,et al.  The Dual Inhibition of RNA Pol I Transcription and PIM Kinase as a New Therapeutic Approach to Treat Advanced Prostate Cancer , 2016, Clinical Cancer Research.

[7]  Youn Wha Kim,et al.  Prognostic value of ERG, PTEN, CRISP3 and SPINK1 in predicting biochemical recurrence in prostate cancer , 2016, Oncology letters.

[8]  K. Iczkowski,et al.  Calcitonin Receptor-Zonula Occludens-1 Interaction Is Critical for Calcitonin-Stimulated Prostate Cancer Metastasis , 2016, PloS one.

[9]  Christopher G. Adda,et al.  Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes , 2015, Oncotarget.

[10]  Chih-Chiang Tsou,et al.  DIA-Umpire: comprehensive computational framework for data-independent acquisition proteomics , 2015, Nature Methods.

[11]  B. Donnelly,et al.  Cysteine- rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients’ prognosis , 2014, Journal of Hematology & Oncology.

[12]  S. Mahale,et al.  Mapping of the binding sites involved in PSP94-CRISP-3 interaction by molecular dissection of the complex. , 2013, Biochimica et biophysica acta.

[13]  R. Schneiter,et al.  Pathogen-Related Yeast (PRY) proteins and members of the CAP superfamily are secreted sterol-binding proteins , 2012, Proceedings of the National Academy of Sciences.

[14]  Tim Beißbarth,et al.  TGF-b signaling , 2022 .

[15]  E. Schuman,et al.  Calcium-dependent dynamics of cadherin interactions at cell–cell junctions , 2011, Proceedings of the National Academy of Sciences.

[16]  M. O’Bryan,et al.  The role of cysteine-rich secretory proteins in male fertility. , 2011, Asian journal of andrology.

[17]  W. Gerald,et al.  Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3 , 2010, Prostate Cancer and Prostatic Diseases.

[18]  S. Mahale,et al.  Growth inhibition mediated by PSP94 or CRISP-3 is prostate cancer cell line specific. , 2010, Asian journal of andrology.

[19]  M. O’Bryan,et al.  Phenotyping male infertility in the mouse: how to get the most out of a ‘non-performer’ , 2009, Human reproduction update.

[20]  J. Carpten,et al.  Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk. , 2009, Human molecular genetics.

[21]  D. J. Merriner,et al.  Cysteine‐rich secretory proteins are not exclusively expressed in the male reproductive tract , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

[22]  N. Suzuki,et al.  Structures of pseudechetoxin and pseudecin, two snake-venom cysteine-rich secretory proteins that target cyclic nucleotide-gated ion channels: implications for movement of the C-terminal cysteine-rich domain. , 2008, Acta crystallographica. Section D, Biological crystallography.

[23]  D. Bikle,et al.  Inactivation of the Calcium Sensing Receptor Inhibits E-cadherin-mediated Cell-Cell Adhesion and Calcium-induced Differentiation in Human Epidermal Keratinocytes* , 2008, Journal of Biological Chemistry.

[24]  M. O’Bryan,et al.  The CAP superfamily: cysteine-rich secretory proteins, antigen 5, and pathogenesis-related 1 proteins--roles in reproduction, cancer, and immune defense. , 2008, Endocrine reviews.

[25]  W. Gerald,et al.  Association of Cysteine-Rich Secretory Protein 3 and β-Microseminoprotein with Outcome after Radical Prostatectomy , 2007, Clinical Cancer Research.

[26]  R. Baxter,et al.  The plant pathogenesis related protein GLIPR-2 is highly expressed in fibrotic kidney and promotes epithelial to mesenchymal transition in vitro. , 2007, Matrix biology : journal of the International Society for Matrix Biology.

[27]  M. O’Bryan,et al.  The Cysteine-rich Secretory Protein Domain of Tpx-1 Is Related to Ion Channel Toxins and Regulates Ryanodine Receptor Ca2+ Signaling* , 2006, Journal of Biological Chemistry.

[28]  H. Lilja,et al.  β-Microseminoprotein binds CRISP-3 in human seminal plasma , 2005, Biochemical and Biophysical Research Communications.

[29]  T. Graeber,et al.  Myc-driven murine prostate cancer shares molecular features with human prostate tumors. , 2003, Cancer cell.

[30]  R. Lewis,et al.  Isolation and Characterization of a Cone Snail Protease with Homology to CRISP Proteins of the Pathogenesis-related Protein Superfamily* , 2003, Journal of Biological Chemistry.

[31]  T. Morita,et al.  Wide distribution of cysteine-rich secretory proteins in snake venoms: isolation and cloning of novel snake venom cysteine-rich secretory proteins. , 2003, Archives of biochemistry and biophysics.

[32]  J. Cheville,et al.  Cysteine-rich secretory protein-3: a potential biomarker for prostate cancer. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[33]  L. Kjeldsen,et al.  Identification of human cysteine‐rich secretory protein 3 (CRISP‐3) as a matrix protein in a subset of peroxidase‐negative granules of neutrophils and in the granules of eosinophils , 2002, Journal of leukocyte biology.

[34]  Matthias Kretzler,et al.  Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue. , 2002, The American journal of pathology.

[35]  George Vasmatzis,et al.  Identification of differentially expressed genes in normal and malignant prostate by electronic profiling of expressed sequence tags. , 2002, Cancer research.

[36]  L. Kjeldsen,et al.  An ELISA for SGP28/CRISP-3, a cysteine-rich secretory protein in human neutrophils, plasma, and exocrine secretions. , 2002, Journal of immunological methods.

[37]  G. Ghandour,et al.  B‐lymphocyte quiescence, tolerance and activation as viewed by global gene expression profiling on microarrays , 2000, Immunological reviews.

[38]  I. Toda,et al.  Expression of transcripts for cysteine‐rich secretory proteins (CRISPs) in the murine lacrimal gland , 1999, Journal of cellular physiology.

[39]  B. Martin,et al.  Isolation and characterization of helothermine, a novel toxin from Heloderma horridum horridum (Mexican beaded lizard) venom. , 1990, Toxicon : official journal of the International Society on Toxinology.